Cancer Type/Condition: Leukemia, acute lymphocytic (ALL), child
Stage/Subtype: untreated childhood acute lymphoblastic leukemia
Country: U.S.A.
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0232, NCT00075725, AALL0232
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 10
Sponsor: NCI
Protocol IDs: COG-AALL0331, AALL0331, NCT00103285
|
|
3.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 3 to 20
Sponsor: NCI
Protocol IDs: HLMCC-0402, NCT00369564, ACCL 0731
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: NCI
Protocol IDs: DFCI-05001, NCT00400946
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0434, AALL0434, NCT00408005
|
|
6.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and under at diagnosis
Sponsor: NCI
Protocol IDs: COG-AALL0631, AALL0631, NCT00557193
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: TOTXVI, NCT00549848
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 0 to 55
Sponsor: Other
Protocol IDs: 8717, NCT00673114
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: NCI
Protocol IDs: CPMC-IRB-AAAA5571, CPMC-CAMP-016, NCI-G00-1891, NCT00008216
|
|
10.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1898.00, 5788, NCT00089011
|
|
11.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: FHCRC-1938.00, 5887, NCT00105001
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 24 months
Sponsor: Other
Protocol IDs: INF-T2, NCT00145626
|
|
13.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: CINJ-3330, NCT00161187
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: ID02-230, NCT00671658
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 11300A, NCT00683046
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 70
Sponsor: NCI, NHLBI
Protocol IDs: 606, U01 HL069294, NCT00864227
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCT00866749
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P2 L-D AB, NCT00917826
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 1 to 16
Sponsor: Other
Protocol IDs: 20010133, NCT00460421
|
|
20.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 and over
Sponsor: Other
Protocol IDs: 2008-0384, NCT00761644
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2009-0226, NCT00940381
|
|
22.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 2007-0183, NCT00506597
|
|
23.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: DCOG-INTERFANT-06, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, NCT00550992, CCLG-LK-2006-10
|
|
24.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: COG-AALL07P4, AALL07P4, NCT00671034
|
|
25.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 30 at diagnosis
Sponsor: NCI
Protocol IDs: COG-AALL08P1, AALL08P1, NCT00866307
|
